Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72
Doxorubicin (Dox) is an antitumor agent used in cancer treatment, but its clinical use is limited due to cardiotoxicity. Although exercise training can defend against Dox-mediated cardiac damage, the means for this cardioprotection remain unknown. To investigate the mechanism(s) responsible for exer...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Heart and circulatory physiology 2010-11, Vol.299 (5), p.H1515-H1524 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!